UKCA Mark Will Be The Post-EU Route To The British Medtech Market In January 2021
Brexit transition-end rules decided for UK market access
New MHRA guidance says the EU CE marking will continue to be used for devices and diagnostics in Great Britain until June 2023, and thereafter a standalone regulatory system will come into place.
You may also be interested in...
Although the EU MDR and IVDR will fall outside the scope of new post-Brexit medtech regulations for Great Britain in 2021, the UK MHRA says it has the chance of developing its own world-leading regulatory regime.
The end of the traditional EU holiday period is nearing, and the pace of regulatory activity is expected to pick up sharply as September gets underway. What can medtech expect for the rest of 2020 and into the first half of 2021, in these unprecedented times?
With the Brexit implementation period ending in four months, the UK government has launched a trade advisory group for international life sciences deal talks and given UK medtech a seat at the table.